Abstract:Abstract Background The CRISPR-Cas12a (formerly Cpf1) system is a versatile gene-editing tool with properties distinct from the broadly used Cas9 system. Features such as recognition of T-rich protospacer-adjacent motif (PAM) and generation of sticky breaks, as well as amenability for multiplex editing in a single crRNA and lower off-target nuclease activity, broaden the targeting scope of available tools and enable more accurate genome editing. However, the widespread use of the nuclease for gene editing, especially in clinical applications, is hindered by insufficient activity and specificity despite previous efforts to improve the system. Currently reported Cas12a variants achieve high activity with a compromise of specificity. Here, we used structure-guided protein engineering to improve both editing efficiency and targeting accuracy of Acidaminococcus sp. Cas12a ( As Cas12a) and Lachnospiraceae bacterium Cas12a ( Lb Cas12a). Results We created new As Cas12a variant termed “ As Cas12a-Plus” with increased activity (1.5~2.0-fold improvement) and specificity (reducing off-targets from 29 to 23 and specificity index increased from 92% to 94% with 33 sgRNAs), and this property was retained in multiplex editing and transcriptional activation. When used to disrupt the oncogenic BRAF V600E mutant, As Cas12a-Plus showed less off-target activity while maintaining comparable editing efficiency and BRAF V600E cancer cell killing. By introducing the corresponding substitutions into Lb Cas12a, we also generated Lb Cas12a-Plus (activity improved ~1.1-fold and off-targets decreased from 20 to 12 while specificity index increased from 78% to 89% with 15 sgRNAs), suggesting this strategy may be generally applicable across Cas12a orthologs. We compared Cas12a-Plus, other variants described in this study, and the reported enCas12a-HF, enCas12a, and Cas12a-ultra, and found that Cas12a-Plus outperformed other variants with a good balance for enhanced activity and improved specificity. Conclusions Our discoveries provide alternative As Cas12a and Lb Cas12a variants with high specificity and activity, which expand the gene-editing toolbox and can be more suitable for clinical applications.

Engineered CRISPR-Cas9 nucleases with altered PAM specificities

Engineered CRISPR-Cas9 nuclease with expanded targeting space

Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants

Genome Editing in Zebrafish by ScCas9 Recognizing NNG PAM

CRISPR-Cas12a System With Synergistic Phage Recombination Proteins for Multiplex Precision Editing in Human Cells

Targeted Gene Disruption by CRISPR/xCas9 System in Drosophila Melanogaster.

Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9

Genome editing with natural and engineered CjCas9 orthologs

SpG and SpRY variants expand the CRISPR toolbox for genome editing in zebrafish

Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease

Versatile and robust genome editing with Streptococcus thermophilus CRISPR1-Cas9

Rationally engineered Cas9 nucleases with improved specificity

Engineer Chimeric Cas9 to Expand PAM Recognition Based on Evolutionary Information

Efficient genome editing using modified Cas9 proteins in zebrafish

Programmable Base Editing of Zebrafish Genome Using A Modified Crispr-Cas9 System

Single nucleotide polymorphism in the genomic target affects the recombination efficiency of CRISPR/Cas9-mediated gene editing in zebrafish

Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity

Genome engineering using the CRISPR-Cas9 system

Engineered transcription-associated Cas9 targeting in eukaryotic cells

Rational Design of Enhanced Nme2Cas9 and Nme2 Cas9 Nucleases and Base Editors